Cameron John Reynolds - Jun 23, 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: President and CEO, Director
Signature: /s/ Cameron John Reynolds
Stock symbol: VNRX
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/24/2022, 04:04 PM
Previous filing: Apr 8, 2022
Next filing: Aug 30, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Award	$0	+32.3K	+2.78%	$0.00	1.19M	Jun 23, 2022	Direct	F1
holding	VNRX	Common Stock						1.01M	Jun 23, 2022	By Concord International, Inc.	F2
holding	VNRX	Common Stock						34.1K	Jun 23, 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Award	$0	+59.5K	+185.72%	$0.00	91.5K	Jun 23, 2022	Common Stock	59.5K	$3.40	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 3, 2021, the reporting person was awarded 49,645 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 32,270 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 16,136 units and 16,134 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in April 2022, the rights with respect to the remaining 17,375 restricted stock units subject to the award previously vested and remain subject to time-based vesting.
F2	The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.
F3	On August 3, 2021, the reporting person was granted an option to purchase 91,486 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 59,466 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 29,733 shares on each of August 3, 2022 and August 3, 2023, respectively. As reported in April 2022, the rights with respect to the remaining 32,020 shares subject to the award previously vested and remain subject to time-based vesting.